Skip to main
VSTM
VSTM logo

Verastem (VSTM) Earnings Dates & Reports

Verastem (VSTM) Most Recent Earnings

Report DateAug 7, 2025
Period EndingQ2 2025
Est. EPS-$0.68
Actual EPS-$0.63
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Verastem (VSTM) Earnings per Share (EPS) History

Signup for full access
Browse free

Verastem (VSTM) Latest Earnings

The value each VSTM share was expected to gain vs. the value each share gained.

Verastem (VSTM) reported its most recent earnings on Aug 7, 2025 for Q2 2025, posting earnings per share (EPS) of -$0.63. This exceeded analysts' expectations of -$0.68 by 7.35%, marking a Beat.

For comparison, Verastem reported EPS of -$0.61 in the same quarter last year.

The company is expected to announce its next earnings report on 11/05/2025, with analysts projecting an EPS of -$0.65.

Verastem (VSTM) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Nov 6, 2025
-$0.65Next earnings call Nov. 5, 2025
Q2 2025Aug 7, 2025
-$0.68-$0.63-7.35%
Q1 2025Sep 5, 2025
-$0.61-$0.79+29.51%
Q4 2024Mar 19, 2025
-$0.81-$0.60-25.93%
Q3 2024Nov 6, 2024
-$0.74-$0.88+18.92%
View all

Verastem (VSTM) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Verastem’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 7, 2025
May 13, 2025
Mar 20, 2025
Nov 6, 2024

Verastem (VSTM) Earnings FAQs

Verastem (VSTM) last reported earnings on Aug 7, 2025 for Q2 2025, posting an EPS of -$0.63, which Beat the estimate of -$0.68 by 7.35%.

For Q2 2025, Verastem (VSTM) reported an EPS of -$0.63, exceeding analysts' estimate of -$0.68 by 7.35%.

For Q2 2025, Verastem (VSTM) Beat expectations with an actual EPS of -$0.63 vs. an estimated EPS of -$0.68.

Following the last earnings report on Aug 7, 2025, Verastem (VSTM)'s stock price moved — from — to —.

The next Verastem (VSTM) earnings call is scheduled for Nov. 5, 2025, where executives will discuss financial results and outlook.

Verastem (VSTM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.